SOBEI is a biotechnology company specializing in gene therapy to treat age-related diseases. The key assumption of the company is that aging (defined as time-dependent functional decline at the cellular level) is the greatest risk factor for most human pathologies. However, it can be treated. The aging process is located at the intersection of biology, lifestyle and various externalities, leading to cell degeneration, characterized by telomere depletion, mitochondrial dysfunction, epigenetic changes, intercellular and extracellular changes, and genomic instability. These interactions further cascade metabolic dysfunction, cell aging and stem cell failure, leading to inflammation driven diseases and other chronic disease states, such as organ failure, cancer, heart disease, diabetes and dementia.